A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Carsten Flohr, Abaigeal Jackson et al.|Skin Health and Disease|2025Cited by 1
Implementing Federated Analysis Using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, Carsten Flohr, David Prieto‐Merino et al.|Journal of Investigative Dermatology|2025Cited by 0